Cargando…

Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy

BACKGROUND: Breast cancer patients with metabolic syndrome have an increased risk of cardiovascular disease. These patients are more prone to suffer from cardiotoxicity after anticancer therapy. Patients after completion of cancer-related comprehensive therapy, who show normal myocardial function, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Feng, Wang, Siyuan, Liang, Siying, Yu, Chao, Li, Sufang, Chen, Hong, Wang, Shu, Zhu, Tiangang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943305/ https://www.ncbi.nlm.nih.gov/pubmed/33747560 http://dx.doi.org/10.1155/2021/6640673

Ejemplares similares

Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension
por: Seo, Jeong-Min, et al.
Publicado: (2011)

Combined associations of obesity and metabolic health with subclinical left ventricular dysfunctions: Danyang study
por: Wang, Ye, et al.
Publicado: (2021)

Subclinical myocardial dysfunction and dyssynchrony after Ross or Ross-Konno procedure
por: Ellenberger, Katherine, et al.
Publicado: (2020)

Analysis of Subclinical Thyroid Dysfunction and Metabolic Abnormality in 28568 Healthy People
por: Xie, Yan, et al.
Publicado: (2023)

CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients
por: Zhou, Fangli, et al.
Publicado: (2021)

Subclinical myocardial dysfunction is revealed by speckle tracking echocardiography in patients with Cornelia de Lange syndrome
por: Trujillano, Laura, et al.
Publicado: (2022)

Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention
por: Wang, Lan, et al.
Publicado: (2022)

Editorial to QRS fragmentation as a potential new marker for subclinical myocardial dysfunction
por: Hung, Chung‐Lieh, et al.
Publicado: (2020)

Machine learning prediction of progressive subclinical myocardial dysfunction in moderate aortic stenosis
por: Namasivayam, Mayooran, et al.
Publicado: (2023)

Association of inflammatory biomarkers and disease activity with subclinical myocardial dysfunction in psoriatic arthritis
por: Pletikosic, Ivan, et al.
Publicado: (2023)

Two-dimensional speckle tracking echocardiography in assessing the subclinical myocardial dysfunction in patients with gestational diabetes mellitus
por: Li, Wei, et al.
Publicado: (2022)

Detection of subclinical myocardial dysfunction in cocaine addicts with feature tracking cardiovascular magnetic resonance
por: Maceira, Alicia M., et al.
Publicado: (2020)

Subclinical Myocardial Dysfunction Demonstrated by Speckle Tracking Echocardiography in Children with Euthyroid Hashimoto’s Thyroiditis
por: Azak, Emine, et al.
Publicado: (2019)

Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19
por: Luchian, Maria-Luiza, et al.
Publicado: (2021)

Early echocardiographic screening for subclinical myocardial dysfunction in children and adolescents with dyslipidemia: why and when?
por: Lee, Hyun Gyung, et al.
Publicado: (2022)

Subclinical left ventricular myocardial dysfunction in patients with obstructive sleep apnea syndrome: insights from noninvasive left ventricular myocardial work analysis
por: Jin, Shan, et al.
Publicado: (2022)

Hidden danger of COVID-19 outbreak: evaluation of subclinical myocardial dysfunction in patients with mild symptoms
por: GUL, Murat, et al.
Publicado: (2021)

Subclinical myocardial dysfunction and reduced left ventricular global longitudinal strain in patients with COVID-19
por: Lee, Wei-Chieh
Publicado: (2021)

Subclinical Myocardial Dysfunction in Patients Recovered from COVID-19 Disease: Correlation with Exercise Capacity
por: Shimoni, Or, et al.
Publicado: (2021)

Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancer
por: Alıcı, Hayri, et al.
Publicado: (2015)

Subclinical Cushing's Syndrome and Metabolic Disorder
por: Bae, Ji Cheol
Publicado: (2014)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients
por: Wibawa Martha, Januar, et al.
Publicado: (2020)

Associations between Subclinical Myocardial Dysfunction and Premature Fusion of Early and Late Diastolic Filling with Uncertain Cause
por: Kim, Kyu, et al.
Publicado: (2022)

Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study
por: Péter, Andrea, et al.
Publicado: (2022)

The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome
por: Ertürk, Mehmet, et al.
Publicado: (2015)

Assessment of subclinical left ventricle myocardial dysfunction using global myocardial work in type 2 diabetes mellitus patients with preserved left ventricle ejection fraction
por: Wang, Tao, et al.
Publicado: (2022)

Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
por: dos Santos, Marília Harumi Higuchi
Publicado: (2013)

Acute and Subclinical Myocardial Injury in COVID-19
por: Crudo, Valentina L., et al.
Publicado: (2021)

Gender-Specific Differences on the Association of Hypertension with Subclinical Thyroid Dysfunction
por: Zhang, Jingkai, et al.
Publicado: (2019)

The Nonlinear Correlation Between a Novel Metabolic Score for Insulin Resistance and Subclinical Myocardial Injury in the General Population
por: Wang, Zhenwei, et al.
Publicado: (2022)

Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer
por: Gasiorowska, A., et al.
Publicado: (2015)

Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus
por: Todo, Saki, et al.
Publicado: (2021)

Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19
por: Shmueli, Hezzy, et al.
Publicado: (2021)

Left ventricular global longitudinal strain imaging in identifying subclinical myocardial dysfunction among covid-19 survivors
por: Kujur, Punya Pratap, et al.
Publicado: (2022)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

Comprehensive molecular biomarker identification in breast cancer brain metastases
por: Schulten, Hans-Juergen, et al.
Publicado: (2017)

Identification of common genetic features and pathways involved in pulmonary lymphangioleiomyomatosis and ER-positive breast cancer
por: Yang, Lulu, et al.
Publicado: (2023)

Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines
por: Toro-Salazar, Olga H., et al.
Publicado: (2018)

Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work
por: Li, Guang-An, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0sindvraj9rj44cmkkk17eorum